Tarsus Pharmaceuticals files S-3ASR
- Filed S-3ASR on 2026-10-13
- Registering 2,908,692 shares of common stock
- Selling stockholders to resell shares from acquisition
TARS
Tarsus Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for Tarsus Pharmaceuticals, Inc. (TARS), newest first, with AI summaries and stories.
- Ticker
- TARS
- CIK
- 1819790
- Latest filing
- 5d
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINES-3ASRTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINES-3ASRTarsus Pharmaceuticals, Inc.TARSLIVE Tarsus Pharmaceuticals files S-3ASR
- Filed S-3ASR on 2026-10-13
- Registers up to 2,232,144 shares of common stock
- Includes 133,625 shares from pre-funded warrants
ROUTINE8-K/ATarsus Pharmaceuticals, Inc.TARSLIVE Tarsus Pharmaceuticals acquires Alkeus
- Filed 8-K/A on 2026-10-13
- Includes Alkeus financial statements
- Pro forma financial info provided
ROUTINE4Tarsus Pharmaceuticals, Inc.TARSLIVE 3 insider filings
David E I Pyott, insider filing for TARS
Show all 3
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
David E I Pyott, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE William J Phd Link, planned sale of TARS shares
William J Link Phd, reporting
ROUTINE8-KTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE4Tarsus Pharmaceuticals, Inc.TARSLIVE 3 insider filings
Bobak R. Azamian, insider filing for TARS
Show all 3
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
Bobak R. Azamian, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE Bobak R. Azamian, planned sale of TARS shares
Bobak R. Azamian, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE 3 Form 144 notices
Elizabeth Yeu Lin, planned sale of TARS shares
Show all 3
- 144Planned insider sale of TARS shares
- 144Planned insider sale of TARS shares
- 144Planned insider sale of TARS shares
Elizabeth Yeu Lin, reporting
ROUTINE4Tarsus Pharmaceuticals, Inc.TARSLIVE 2 insider filings
Elizabeth Yeu Lin, insider filing for TARS
Show all 2
- 4Insider filing for TARS
- 4Insider filing for TARS
Elizabeth Yeu Lin, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE 4 Form 144 notices
Elizabeth Yeu Lin, planned sale of TARS shares
Show all 4
- 144Planned insider sale of TARS shares
- 144Planned insider sale of TARS shares
- 144Planned insider sale of TARS shares
- 144Planned insider sale of TARS shares
Elizabeth Yeu Lin, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE Aziz Mottiwala, planned sale of TARS shares
Aziz Mottiwala, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE Elizabeth Yeu Lin, planned sale of TARS shares
Elizabeth Yeu Lin, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE Aziz Mottiwala, planned sale of TARS shares
Aziz Mottiwala, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE Aziz Mottiwala, planned sale of TARS shares
Aziz Mottiwala, reporting
ROUTINESCHEDULE 13G/ATarsus Pharmaceuticals, Inc.TARSLIVE Ownership stake disclosure by Janus Henderson Group Ltd. (amended)
Janus Henderson Group Ltd., filed by
NOTABLE10-QTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE8-KTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE8-KTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE8-KTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE8-KTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE8-KTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE4Tarsus Pharmaceuticals, Inc.TARSLIVE 7 insider filings
Andrew D. Goldberg, insider filing for TARS
Show all 7
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
Andrew D. Goldberg, reporting
ROUTINE8-KTarsus Pharmaceuticals, Inc.TARSLIVE ROUTINE4Tarsus Pharmaceuticals, Inc.TARSLIVE Bobak R. Azamian, insider filing for TARS
Bobak R. Azamian, reporting
ROUTINE4Tarsus Pharmaceuticals, Inc.TARSLIVE 3 insider filings
Jeffrey S Farrow, insider filing for TARS
Show all 3
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
Jeffrey S Farrow, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE Bobak R. Azamian, planned sale of TARS shares
Bobak R. Azamian, reporting
ROUTINE144Tarsus Pharmaceuticals, Inc.TARSLIVE Jeffrey S Farrow, planned sale of TARS shares
Jeffrey S Farrow, reporting
ROUTINE4Tarsus Pharmaceuticals, Inc.TARSLIVE 4 insider filings
Wendy L Yarno, insider filing for TARS
Show all 4
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
- 4Insider filing for TARS
Wendy L Yarno, reporting